GSK-3 and Tau: a key duet in Alzheimer's disease

CL Sayas, J Ávila - Cells, 2021 - mdpi.com
Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase
with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a …

Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1

K Maiese - Neural regeneration research, 2021 - journals.lww.com
The global increase in lifespan noted not only in developed nations, but also in large
developing countries parallels an observed increase in a significant number of non …

DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson's disease: a mutual relationship

M Alrouji, HM Al-Kuraishy, AK Al-Buhadily… - Pharmacological …, 2023 - Springer
Parkinson's disease (PD) usually occurs due to the degeneration of dopaminergic neurons
in the substantia nigra (SN). Management of PD is restricted to symptomatic improvement …

Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics

S Fang, Z Wu, Y Guo, W Zhu, C Wan, N Yuan… - Frontiers in …, 2023 - frontiersin.org
Adult hippocampal neurogenesis generates functional neurons from neural progenitor cells
in the hippocampal dentate gyrus (DG) to complement and repair neurons and neural …

The link between Alzheimer disease and metabolic syndrome: A mutual relationship and long rigorous investigation

HM Al-Kuraishy, MS Jabir, AK Albuhadily… - Ageing Research …, 2023 - Elsevier
It has been illustrated that metabolic syndrome (MetS) is associated with Alzheimer disease
(AD) neuropathology. Components of MetS including central obesity, hypertension, insulin …

Cognitive impairment and dementia: gaining insight through circadian clock gene pathways

K Maiese - Biomolecules, 2021 - mdpi.com
Neurodegenerative disorders affect fifteen percent of the world's population and pose a
significant financial burden to all nations. Cognitive impairment is the seventh leading cause …

[HTML][HTML] Nicotinamide as a foundation for treating neurodegenerative disease and metabolic disorders

K Maiese - Current neurovascular research, 2021 - ncbi.nlm.nih.gov
Neurodegenerative disorders impact more than one billion individuals worldwide and are
intimately tied to metabolic disease that can affect another nine hundred individuals …

[HTML][HTML] Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm

K Maiese - Frontiers in bioscience (Landmark edition), 2021 - ncbi.nlm.nih.gov
Methods and results: Novel work with biological clock genes that oversee circadian rhythm
may meet this critical need by focusing upon the pathways of the mechanistic target of …

Cortical dopamine D5 receptors regulate neuronal circuit oscillatory activity and memory in rats

AM Albeely, CJ Nolan, DJ Rasmussen… - CNS Neuroscience …, 2023 - Wiley Online Library
Introduction The dopamine D5 receptor (D5R) shows high expression in cortical regions, yet
the role of the receptor in learning and memory remains poorly understood. This study …

[HTML][HTML] The metabolic basis for nervous system dysfunction in alzheimer's disease, parkinson's disease, and huntington's disease

K Maiese - Current neurovascular research, 2023 - ncbi.nlm.nih.gov
Disorders of metabolism affect multiple systems throughout the body, but may have the
greatest impact on both central and peripheral nervous systems. Current available …